Join Dr Artiene Tatian, dermatologist and Ms Melanie Funk to discuss the impact and burden of eczema on individuals and practical tips for managing patients with eczema. Hosted by Medcast medical adviser, Dr Kate Annear.
Eczema is an increasingly common condition that is often managed in the primary care setting. It usually presents early in life and is often viewed as a minor condition. However, this belies the reality that for many sufferers, eczema can be a debilitating chronic condition. Ongoing management can be complex, time-consuming, and expensive, with patients and their families experiencing physical, mental, emotional, and financial burdens.
The impact and burden of eczema on individuals and families in Australia.
Some of the challenges that health professionals are facing in treating patients with eczema.
Some practical advice that health professionals can take home including clinical tips and suggested resources to use with patients.
We will also be introducing the QUM Alliance eczema program and the educational activities that will follow in the coming months.
This podcast is brought to you by Medcast and the Quality Use of Medicines Alliance.
For more free Quality Use of Medicines education, check out QHUB on Medcast
Join Jack Steele as he shares his journey with severe eczema, discussing challenges and strategies for managing the condition. A must-listen for those seeking support and insights.
Join Dr Kate Annear as she discusses Gout with Professor Ric Day, a highly experienced rheumatologist and clinical pharmacologist. This podcast will cover why gout is important, and will also address some of the common misconceptions surrounding this condition as well as providing some practical advice on supporting better outcomes in the management of this condition.
Gout, a chronic inflammatory condition, is often undertreated despite its impact on quality of life. Misconceptions include it being only a lifestyle disease or affecting only older men. Effective management requires lifelong urate-lowering therapy and addressing both pharmacologic and non-pharmacologic factors.